Glatiramer acetate (Compound)

Synonyms:Glatiramer acetate, 147245-92-9, acetic acid;(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid, Glatirameracetat, DTXSID30163637, C9H11NO3.C6H14N2O2., AM84438, AC-28732, L-alanine compound with L-glutamic acid and L-lysine and L-tyrosine and acetic acid (1:1:1:1:1), AB0110033, Y0429, Q418274

Pubchem:PUBCHEM:3081884

Id:36396f1e-a505-5501-b871-f7070676b336

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Glatiramer acetate's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Glatiramer acetate.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Glatiramer acetate.

Results found

Linked to

	Label	Description
	DCSTRUCT ID 04880 Collection (Entity type)	DrugPage Collection: (DrugCentralID:04880; PubChem_CID:3081884, FILE=drugcentral_drug_04880.json)
	Glatiramer acetate indication Multiple Sclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

DCSTRUCT ID 04880

Collection (Entity type)

DrugPage Collection: (DrugCentralID:04880; PubChem_CID:3081884, FILE=drugcentral_drug_04880.json)

Glatiramer acetate indication Multiple Sclerosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.